full
without
#666666
http://www.aurorabiomed.com/wp-content/themes/aurora-clean/
http://www.aurorabiomed.com/
#0066FF
style2

Speaking Program 2014

ionChannelRetreatLogo2014

Speaking Program

 

Wednesday, June 25th, 2014

  • 7:30 – 8:30 Registration & Breakfast
  • 8:30 – 8:35 Welcome & Opening Remarks – Aurora Biomed Inc.

Screening Technologies 1

  • 9:55 – 10:25 Coffee Break
  • 11:40 – 12:40 Lunch

Ion Channels as Pain Targets

  • 12:40 – 1:45 Chairperson’s Remarks- Edward Stevens
  • 12:45 – 1:10 Edward Stevens – Head of Ion Channel Pharmacology, Pfizer – Use of selective small molecule Nav1.7 inhibitors to investigate the role of Nav1.7 in sensory neuron excitability
  • 1:10 – 1:35 Jeff Krajewski, Senior Research Scientist, Eli Lilly and Company – Use of local anesthetic binding site mutations to develop selective Nav1.7blockers for pain
  • 1:35 – 2:00 Margaret Lee, Vice President, Research & Translational Medicine, Zalicus – Z944: An oral T-type calcium channel modulator for the treatment of pain
  • 2:00 – 2:30 Coffee Break
  • Wine and Cheese Reception Sponsored by SB Ion Channels

Thursday, June 26th, 2014

  • 7:30 AM – 8:30 AM – Breakfast
  • 8:30 AM – 8:35 AM – Opening Remarks – Aurora Biomed Inc.

Screening Technologies 2

  • 8:35 – 9:00 KEYNOTE: Arthur “Buzz” Brown – CEO, ChanTest Corporation – How ChanTest does CiPA
  • 9:00 – 9:05 Chairperson’s Remarks- Arthur “Buzz” Brown
  • 9:05 – 9:30 Yang Wen,  Principle Associate,  Hoffmann-La Roche – Development of an ion flux assay and full library screening campaign for modulators of a cation-chloride co-transporter
  • 9:30 – 9:55 Richard Kondo – North America Sales Manager, Sophion Bioscience, Inc. – A Qube update: high fidelity ion channel recordings and HTS assay quality in 384 format
  • 9:55 – 10:25 Coffee Break
  • 11:40 – 12:40 Lunch

Ion Channels as Disease Targets

  • 12:40 – 12:45 Chairperson’s Remarks- Maria Garcia and Gregory Kaczarowski
  • 12:45 – 1:10 Maria Garcia & Gregory Kaczorowski –  Kanalis Consulting, L.L.C. – Discovery of novel, selective, potent inhibitors of an inwardly-rectifying potassium channel
  • 1:10 – 1:35 Heike Wulff – Professor, Department of Pharmacology, University of California, Davis – The potassium channels Kv1.3 and KCa3.1 as targets for inflammatory brain pathologies
  • 1:35 – 2:00 Saverio Gentile – Assistant Professor, Loyola University – Stimulation of potassium channels in cancer cells. The on/off master switch for tumor suppressor and oncogenes
  • 2:00 – 2:30 Coffee Break
  • Harbour Boat Cruise Sponsored by ChanTest – Shuttle times TBD

Friday, June 27th, 2014

  • 7:30 AM – 8:30 AM – Breakfast
  • 8:30 AM – 8:35 AM – Opening Remarks – Aurora Biomed Inc.

Transporters and Ion Pumps

  • 10:20 – 10:50 Coffee Break

 

Structure and Function of Ion Channels

  • 11:45 -12:45 Lunch
  • 12:45 – 1:10Armagan Kocer, Assistant Professor, Department of Neuroscience, University Medical Centre Groningen – Watching an ion channel gating
  • 1:10 – 1:35 Onkar Tripathi, President, Ion Channel Study Group, Life Sciences Academy –  Molecular actions of fendiline, a unique Ca2+ channel blocker

Cardiac Safety and Pharmacology

  • 1:35 – 1:40 Chairperson’s Remarks- Balwant Tuana
  • 1:40 – 2:05 Balwant Tuana, Professor, University of Ottawa – Novel modulators  of ion transport as therapeutic targets in heart disease
  • 2:05 – 2:30 Ken Gibson – President and CSO, Ionic Transport Assay – Evaluation of drug mediated changes in action potentials recorded from adult human stem cell derived cardiomyocytes
  • 2:30 – 3:00 Coffee Break
  • 3:00- 3:25 Adam Hill, Professor, St. Vincent’s Clinical School, Victor Chang University – Kinetics of drug interaction with the Kv11.1 potassium channel
  • 3:25 – 3:50 Peter Ruben, Professor, Simon Fraser University – Acidosis and temperature: twin arrhythmogenic triggers in Long QT3 and  Brugada Syndromes
  • Dong Liang, President & CEO, Aurora Biomed Inc. – Closing Remarks
default
Loading posts...
link
#6E787E
on
fadeInUp
loading
#6E787E
off
Back